---
schema_version: "secwatch.filing_event.v1"
accession: "0002019410-26-000046"
form_type: "8-K"
ticker: "CAI"
cik: "0002019410"
company_name: "Caris Life Sciences, Inc."
filed_at: "2026-06-05T21:03:34+00:00"
generated_at: "2026-06-05T21:04:21.748441+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Caris Life Sciences shareholders elect ten directors, ratify Deloitte as auditor for FY2026

## Summary
- Annual Meeting held June 4, 2026; 273.7M shares represented (96.8% of 282.7M outstanding).
- All ten director nominees elected with votes ranging from 200.4M to 228.7M in favor.
- Deloitte & Touche LLP ratified as independent auditor: 273.5M for, 60.9K against, 136.3K abstentions.
- Broker non-votes of 11.1M recorded on director election but not on auditor ratification.

## SEC filing metadata
- accession: 0002019410-26-000046
- form_type: 8-K
- ticker: CAI
- cik: 0002019410
- company_name: Caris Life Sciences, Inc.
- filed_at: 2026-06-05T21:03:34+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2019410/000201941026000046/0002019410-26-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2019410/000201941026000046/cai-20260604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002019410-26-000046
- JSON: https://secwatch.observer/filing/0002019410-26-000046.json
- Plain text: https://secwatch.observer/filing/0002019410-26-000046.txt

## Key facts
- Shareholder Votes
  Caris Life Sciences, Inc. shareholders approved Election of ten director nominees to hold office until the 2027 Annual Meeting at the 2026-06-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2019410/000201941026000046/0002019410-26-000046-index.htm
- Shareholder Votes
  Caris Life Sciences, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm at the 2026-06-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: The selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by the shareholders by the votes set forth in the table below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2019410/000201941026000046/0002019410-26-000046-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.